GATC Wins €750,000 Contract to Sequence Pediatric Brain Tumors for German ICGC Project

Under the contract, the German sequencing service provider will use Illumina sequencing technology, including a HiSeq 2000 instrument the company received this week, to sequence the genomes of brain tumors and matching normal controls from the same patient at 30-fold coverage.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.